Tokyo, Japan

Harumi Ogawa

This inventor holds 5 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harumi Ogawa. Retrieved from https://idiyas.com/inventor/harumi-ogawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Kawasaki, JP (1997)
  • Tokyo, JP (1998 - 2003)

Company Filing History:


Years Active: 1997-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Harumi Ogawa: Innovator in Tyrosine Kinase Inhibition

Introduction

Harumi Ogawa is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmacology, particularly in the development of compounds with tyrosine kinase inhibition activity. With a total of 5 patents to her name, Ogawa's work is recognized for its potential therapeutic applications.

Latest Patents

One of her latest patents focuses on Radicicol derivatives. These derivatives are represented by a specific formula and are noted for their pharmacologically acceptable salts. The innovation lies in their ability to inhibit tyrosine kinase, which is crucial in various cellular processes.

Career Highlights

Harumi Ogawa is currently employed at Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. Her role at the company allows her to further her research and development efforts in innovative drug solutions.

Collaborations

Throughout her career, Ogawa has collaborated with notable colleagues, including Shiro Akinaga and Yoji Ino. These partnerships have enhanced her research capabilities and contributed to the success of her projects.

Conclusion

Harumi Ogawa's contributions to the field of pharmacology, particularly through her innovative work on Radicicol derivatives, highlight her role as a leading inventor. Her ongoing research continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…